Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tiao, Mao Meng ^a   Huang, Li Tung ^a   Chen, Chih Jen ^a   Sheen, Jiunn Ming ^a   Tain, You Lin ^a   Chen, Chih Cheng ^a   Kuo, Ho Chang ^a   Huang, Ying Hsien ^a   Tang, Kuo Shu ^a   Chu, En Wei ^a   Yu, Hong Ren ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DEXAMETHASONE; DNA METHYLTRANSFERASE; GLUCOCORTICOID; HISTONE DEACETYLASE; INTERLEUKIN 6; LEPTIN; MELATONIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA METHYLATION; ENZYME ACTIVITY; ENZYME MECHANISM; FATTY LIVER; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; LABOR INDUCTION; MALE; NICK END LABELING; NONHUMAN; PRENATAL EXPOSURE; PROTEIN EXPRESSION; PROTEIN METHYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG EFFECTS; LIVER; METABOLISM; PATHOLOGY; PREGNANCY;

ANIMALS; APOPTOSIS; CYTOKINES; FATTY LIVER; FEMALE; GLUCOCORTICOIDS; LIVER; MALE; MELATONIN; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84900035445     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/942172     Document Type: Article

References (36)

1. Kapoor A., Petropoulos S., Matthews S. G., Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Research Reviews 2008 57 2 586 595 2-s2.0-40749107391 10.1016/j.brainresrev.2007.06.013
2. Varcoe T. J., Boden M. J., Voultsios A., Salkeld M. D., Rattanatray L., Kennaway D. J., Characterisation of the maternal response to chronic phase shifts during gestation in the rat: implications for fetal metabolic programming. PLoS ONE 2013 8 e53800
3. Entringer S., Buss C., Wadhwa P. D., Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Current Opinion in Endocrinology, Diabetes and Obesity 2010 17 6 507 516 2-s2.0-78649327876 10.1097/MED.0b013e3283405921
4. Drake A. J., Raubenheimer P. J., Kerrigan D., McInnes K. J., Seckl J. R., Walker B. R., Prenatal dexamethasone programs expression of genes in liver and adipose tissue and increased hepatic lipid accumulation but not obesity on a high-fat diet. Endocrinology 2010 151 4 1581 1587 2-s2.0-77950204178 10.1210/en.2009-1088
5. Pogribny I. P., Tryndyak V. P., Bagnyukova T. V., Melnyk S., Montgomery B., Ross S. A., Latendresse J. R., Rusyn I., Beland F. A., Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. Journal of Hepatology 2009 51 1 176 186 2-s2.0-67349089950 10.1016/j.jhep.2009.03.021
6. Thornburg K. L., Shannon J., Thuillier P., Turker M. S., In Utero life and epigenetic predisposition for disease. Advances in Genetics 2010 71 58 78 2-s2.0-77957333516 10.1016/B978-0-12-380864-6.00003-1
7. Ducroc R., Sakar Y., Fanjul C., Barber A., Bado A., Lostao M. P., Luminal leptin inhibits L-glutamine transport in rat small intestine: involvement of ASCT2 and B0AT1. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010 299 1 G179 G185 2-s2.0-77954366369 10.1152/ajpgi.00048.2010
8. Garfield A. S., Patterson C., Skora S., Gribble F. M., Reimann F., Evans M. L., Myers M. G. Jr., Heisler L. K., Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract. Endocrinology 2012 153 4600 4607
9. Gautron L., Elmquist J. K., Sixteen years and counting: an update on leptin in energy balance. Journal of Clinical Investigation 2011 121 6 2087 2093 2-s2.0-79957896666 10.1172/JCI45888
10. Reiter R. J., Tan D.-X., Terron M. P., Flores L. J., Czarnocki Z., Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochimica Polonica 2007 54 1 1 9 2-s2.0-33947592217
11. Zhong M., Xue Z. G., Cang J., Wu W., Huang J. F., Zhu D. M., Protective effect of melatonin on reexpansion pulmonary edema in rats model. Chinese Medical Journal 2013 126 500 504
12. Zaitone S., Hassan N., El-Orabi N., El-Awady E.-S., Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. European Journal of Pharmacology 2011 662 1-3 70 77 2-s2.0-79957610682 10.1016/j.ejphar.2011.04.049
13. Hauser J., Feldon J., Pryce C. R., Direct and dam-mediated effects of prenatal dexamethasone on emotionality, cognition and HPA axis in adult Wistar rats. Hormones and Behavior 2009 56 4 364 375 2-s2.0-70349737605 10.1016/j.yhbeh.2009.07.003
14. Tiao M.-M., Lin T.-K., Kuo F.-Y., Huang C.-C., Du Y.-Y., Chen C.-L., Chuang J.-H., Early stage of biliary atresia is associated with significant changes in 8-hydroxydeoxyguanosine and mitochondrial copy number. Journal of Pediatric Gastroenterology and Nutrition 2007 45 3 329 334 2-s2.0-34548704049 10.1097/MPG.0b013e3180cc2c0f
15. Perfield J. W. II, Ortinau L. C., Pickering R. T., Ruebel M. L., Meers G. M., Rector R. S., Altered hepatic lipid metabolism contributes to nonalcoholic Fatty liver disease in leptin-deficient ob/ob mice. Journal of Obesity 2013 2013 8 296537 10.1155/2013/296537
16. Ravussin E., Smith S. R., Mitchell J. A., Shringarpure R., Shan K., Maier H., Koda J. E., Weyer C., Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity 2009 17 9 1736 1743 2-s2.0-69749086148 10.1038/oby.2009.184
17. Oral E. A., Simha V., Ruiz E., Andewelt A., Premkumar A., Snell P., Wagner A. J., DePaoli A. M., Reitman M. L., Taylor S. I., Gorden P., Garg A., Leptin-replacement therapy for lipodystrophy. The New England Journal of Medicine 2002 346 8 570 578 2-s2.0-0037148928 10.1056/NEJMoa012437
18. Ferreira D. S., Amaral F. G., Mesquita C. C., Barbosa A. P., Lellis-Santos C., Turati A. O., Santos L. R., Sollon C. S., Gomes P. R., Faria J. A., Cipolla-Neto J., Bordin S., Anhe G. F., Maternal melatonin programs the daily pattern of energy metabolism in adult offspring. PLoS ONE 2012 7 e38795
19. Peliciari-Garcia R. A., Andrade-Silva J., Cipolla-Neto J., Carvalho C. R., Leptin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland. BioMed Research International 2013 2013 8 546516 10.1155/2013/546516
20. Bender C. M., Zingg J.-M., Jones P. A., DNA methylation as a target for drug design. Pharmaceutical Research 1998 15 2 175 187 2-s2.0-0031892481 10.1023/A:1011946030404
21. Catalioto R.-M., Maggi C. A., Giuliani S., Chemically distinct HDAC inhibitors prevent adipose conversion of subcutaneous human white preadipocytes at an early stage of the differentiation program. Experimental Cell Research 2009 315 19 3267 3280 2-s2.0-70350375268 10.1016/j.yexcr.2009.09.012
22. Canbakan B., Senturk H., Canbakan M., Toptas T., Tabak O., Balci H., Olgac V., Ozbay G., Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease? Biomarkers in Medicine 2010 4 2 205 214 2-s2.0-77951497440 10.2217/bmm.09.88
23. Walsh M. J., Vanags D. M., Clouston A. D., Richardson M. M., Purdie D. M., Jonsson J. R., Powell E. E., Steatosis and liver cell apoptosis in chronic hepatitis c: a mechanism for increased liver injury. Hepatology 2004 39 5 1230 1238 2-s2.0-2342559886 10.1002/hep.20179
24. Ferreira D. M. S., Castro R. E., MacHado M. V., Evangelista T., Silvestre A., Costa A., Coutinho J., Carepa F., Cortez-Pinto H., Rodrigues C. M. P., Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia 2011 54 7 1788 1798 2-s2.0-79959755613 10.1007/s00125-011-2130-8
25. Syn W.-K., Choi S. S., Diehl A. M., Apoptosis and cytokines in non-alcoholic steatohepatitis. Clinics in Liver Disease 2009 13 4 565 580 2-s2.0-70349972775 10.1016/j.cld.2009.07.003
26. Thompson C. B., Apoptosis in the pathogenesis and treatment of disease. Science 1995 267 5203 1456 1462 2-s2.0-0028943734
27. Tacke F., Luedde T., Trautwein C., Inflammatory pathways in liver homeostasis and liver injury. Clinical Reviews in Allergy and Immunology 2009 36 1 4 12 2-s2.0-61949261267 10.1007/s12016-008-8091-0
28. Paredes D., Acosta S., Gemma C., Bickford P. C., Role of TNFalpha induced inflammation in delay eyeblink conditioning in young and aged rats. Aging and Disease 2010 1 191 198
29. Canbay A., Feldstein A. E., Higuchi H., Werneburg N., Grambihler A., Bronk S. F., Gores G. J., Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003 38 5 1188 1198 2-s2.0-0142151769 10.1053/jhep.2003.50472
30. Anna Diehl M. A. E., Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. American Journal of Physiology-Gastrointestinal and Liver Physiology 2002 282 1 G1 G5 2-s2.0-0036083787
31. Ferguson-Smith A. C., Chen Y.-F., Newman M. S., May L. T., Sehgal P. B., Ruddle F. H., Regional localization of the interferon- β 2 B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics 1988 2 3 203 208 2-s2.0-0023989527
32. Choi I., Kang H.-S., Yang Y., Pyun K.-H., IL-6 induces hepatic inflammation and collagen synthesis in vivo. Clinical and Experimental Immunology 1994 95 3 530 535 2-s2.0-0028244643
33. Yu Q., Stamenkovic I., Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF- β and promotes tumor invasion and angiogenesis. Genes and Development 2000 14 2 163 176 2-s2.0-0034650486
34. Gao H., Xu L., Li D., Guang L., Deng W., [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-alpha and TGF-beta1 in rats with non-alcoholic fatty liver disease]. Nan Fang Yi Ke Da Xue Xue Bao 2013 33 1661 1664
35. Gäbele E., Dostert K., Hofmann C., Wiest R., Schölmerich J., Hellerbrand C., Obermeier F., DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. Journal of Hepatology 2011 55 6 1391 1399 2-s2.0-80052477222 10.1016/j.jhep.2011.02.035
36. Cao Y., Gao X., Zhang W., Zhang G., Nguyen A. K., Liu X., Jimenez F., Cox C. S. Jr., Townsend C. M. Jr., Ko T. C., Dietary fiber enhances TGF- β signaling and growth inhibition in the gut. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011 301 1 G156 G164 2-s2.0-79959824406 10.1152/ajpgi.00362.2010